EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 8 filers reported holding EVAXION BIOTECH A S in Q3 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,035 | -18.3% | 19,500 | +30.1% | 0.00% | – |
| Q4 2022 | $26,973 | -98.2% | 14,985 | -97.3% | 0.00% | – |
| Q3 2022 | $1,486,000 | +67.7% | 565,009 | +24.5% | 0.00% | – |
| Q2 2022 | $886,000 | +13.2% | 453,986 | +76.9% | 0.00% | – |
| Q1 2022 | $783,000 | +14.8% | 256,650 | +66.1% | 0.00% | – |
| Q4 2021 | $682,000 | – | 154,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 30,743 | $296,000 | 0.40% |
| Maven Securities LTD | 222,806 | $2,148,000 | 0.07% |
| Kepos Capital LP | 37,098 | $358,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 6,859 | $64,000 | 0.00% |
| CREDIT SUISSE AG/ | 40,315 | $389,000 | 0.00% |
| MORGAN STANLEY | 200 | $2,000 | 0.00% |
| UBS Group AG | 2,261 | $22,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |